This study was designed to investigate whether different vascular endothelial growth factor (VEGF) genotypes are associated with ascites formation in cirrhotic patients. Seventy cirrhotic patients were included in the study: 25 cirrhotic patients with ascites and 45 cirrhotic patients without ascites. Patient characteristics were investigated and compared between the two groups. With regard to VEGF genotype, 42 patients were C/C and 28 patients were T/T or C/T. The genotypes T/T or C/T were observed in 23 cases (51%) among the non-ascites group, but in only five cases (20%) among the ascites group. Serum levels of albumin and creatinine, and the VEGF genotypes were significantly different between the two groups. Multiple regression analysis showed that serum levels of creatinine and the VEGF genotypes were significantly correlated with ascites formation. Thus, it can be concluded that VEGF genotyping might be a valuable susceptibility marker for ascites formation in cirrhotic patients.
Introduction
Ascites is a common complication of cirrhosis and the development of ascites carries with it a significant worsening of patients' prognosis. 1 Furthermore, ascites formation sometimes causes other complications, such as spontaneous bacterial peritonitis. 2 In particular, it is well known that refractory ascites is associated with poor survival. 3 Hypoalbuminaemia, portal hypertension and sodium retention due to renal dysfunction are considered to be the major causes of ascites formation in cirrhotic patients. 4, 5 The mechanism of ascites formation has not, however, been fully elucidated and it is likely that several other factors may also be associated with its pathogenesis.
Vascular endothelial growth factor (VEGF) is one of the most potent growth factors in the liver and is of interest because it has multiple functions. VEGF is also known as the vascular permeability factor and it has been shown to play a possible role in ascites formation. 6, 7 Renner et al. 8 noted the significance of a C/T mutation at the 3′-T Sohda, K Iwata, M Irie et al. VEGF genotypes in cirrhotic patients with ascites untranslated region (UTR) 936 on the VEGF gene. The authors reported that serum VEGF levels were significantly lower in the patients with the genotypes T/T and C/T than in the patients with the genotype C/C. 8 The current study, was designed to investigate whether or not these VEGF genotypes were associated with ascites formation in cirrhotic patients.
Patients and methods

PATIENTS
This prospective, observational study included consecutive Japanese patients with cirrhosis who were admitted to Fukuoka University Hospital, Fukuoka, Japan, from July 2003 to December 2003. Patients with hepatocellular carcinoma (HCC), oesophagogastric varices or hepatic failure were included in the study. All patients gave their informed consent, verbally and written, before entry into the study. The patients were divided into two groups: cirrhotic patients with ascites or without ascites. The differences in patients' characteristics between these two groups were observed.
BLOOD COLLECTION AND SERUM ANALYSES
Blood samples from each patient were collected into two kinds of tube: a plain tube for the blood biochemistry sample, and a tube containing ethylenediaminetetraacetic acid for the genetic analysis sample. Samples in the plain tubes were centrifuged and the serum was analysed for its biochemical content by a conventional automatic analyser. Part of this serum sample was also stored at -20°C until used for VEGF measurement.
SERUM LEVELS OF VEGF
Serum VEGF levels were measured by a chemiluminescence enzyme-linked immunosorbent assay, as described previously. 9, 10 
VEGF GENOTYPING
The VEGF genotyping was performed by a restriction fragment length polymorphism method using the restriction enzyme Nla III (New England Biolabs, Beverly, MA, USA). Briefly, genomic DNA was extracted from whole peripheral blood using the High Pure PCR Template Preparation Kit (Roche Diagnostics, Indianapolis, IN, USA). The 3′-UTR 936 region on the VEGF gene was amplified by polymerase chain reaction (PCR) using the following primer pair: forward primer, 5′-AAG GAA GAG GAG ACT CTG CGC AGA GC-3′; and reverse primer, 5′-TAA ATG TAT GTA TGT GGG TGG GTG TGT CTA CAGG-3′. The PCR thermal profile consisted of one cycle at 95°C for 10 min followed by 30 cycles of denaturation at 95°C, annealing at 64°C and replication at 72°C for 30 s, and a final cycle at 72°C for 10 min. The PCR product (5 µl) was then incubated with 1 µl of Nla III at 37°C for 1 h before electrophoresis on a 2% agarose gel to visualize the results of the genotyping.
STATISTICAL ANALYSIS
Results are expressed as mean ± SD. Differences between the two groups were analysed using the χ 2 test or Wilcoxon's rank sum test. A P-value < 0.05 was considered to be statistically significant. Multiple regression analysis was performed using the multiple logistic regression method. All calculations were performed using a computer program (JMP version 5.1; SAS Institute, Cary, NC, USA).
Results
COMPARISON OF PATIENT CHARACTERISTICS
A total of 70 cirrhotic patients were included in the study. Of these, 44 patients also had HCC without portal vein involvement and 42 patients had oesophageal or gastric T Sohda, K Iwata, M Irie et al. VEGF genotypes in cirrhotic patients with ascites varices. Eleven patients presented with refractory ascites, as defined by a lack of response to a low sodium diet and a high dose of spironolactone plus furosemide or the appearance of diuretic-induced complications. Patient characteristics are shown in Table 1 .
The patients were divided into two groups: 25 cirrhotic patients with ascites and 45 cirrhotic patients without ascites. No differences were found in age, gender ratio, cause of liver disease or alcohol intake between the ascites and the non-ascites groups ( Table 2 ). The existence of HCC and oesophagogastric varices were not related to ascites formation. Serum biochemical analyses demonstrated significantly decreased levels of albumin and increased levels of creatinine, indicative of renal dysfunction, in the ascites group compared with the non-ascites group (P < 0.05).
VEGF: GENOTYPE AND SERUM LEVELS
The VEGF genotype, C/C, was found in 42 patients, while the other 28 patients had either the T/T or C/T genotypes (Fig. 1) . The frequencies of the C and T alleles were 78% and 22%, respectively. The frequencies of the T/T and C/T genotypes in patients with ascites were significantly lower than among those without ascites (P = 0.011). All of the 11 patients with refractory ascites showed the C/C genotype. Serum VEGF levels were 
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variable and no correlation with ascites formation was found. There was also no significant difference between serum VEGF levels in patients with the C/C genotype and levels in patients with the T/T or C/T genotypes (data not shown).
MULTIPLE REGRESSION ANALYSIS
To identify the risk factors for ascites formation in cirrhotic patients, a stepwise multiple logistic regression analysis was performed. Among the variables that showed a P-value < 0.05 based on a univariate analysis, two independent factors (serum creatinine > 0.9 mg/dl and the VEGF C/C genotype) were found to be significantly correlated with ascites formation in cirrhotic patients (Table 3 ).
Discussion
The present study demonstrated the significance of VEGF genotype on ascites formation in cirrhotic patients, as previously found with regard to serum albumin level and renal function. 4, 5 The frequency of the T/T and C/T genotypes in patients with ascites was significantly lower than in patients without ascites, indicating that a Values are mean ± SD unless stated otherwise. VEGF, vascular endothelial growth factor; NS, not statistically significant (P > 0.05). Levels of serum VEGF were variable and did not correlate with ascites formation. In direct contrast to a previous report, 8 there was no correlation between serum VEGF levels and VEGF genotypes in the present study. It was speculated, therefore, that because serum VEGF levels are always changing, it is not possible accurately to demonstrate any significant correlations between serum VEGF and genotype by only taking a measurement at one particular time point as was the case in the present study.
It is well known that VEGF is associated with HCC progression through the mechanism of angiogenesis 11, 12 and higher serum levels of VEGF have been reported in patients with HCC. 13 VEGF produced by HCC cells acts on vascular endothelial cells, leading to the development of new vessels that can supply nutrients to the tumour. 14 In the present study, subjects admitted to hospital with HCC, oesophagogastric varices or hepatic failure were all considered eligible for inclusion. In the present study, serum levels of VEGF were variable whether HCC existed or not so, although subjects with HCC may not have been ideally suitable for the study, it was felt that their inclusion did not significantly affect the formation of ascites.
Portal hypertension has also been considered to be associated with ascites formation. 4, 5 The frequency of patients with oesophagogastric varices in the groups with or without ascites were similar. It was not possible, therefore, to clarify the relationship between portal hypertension and ascites formation, and further studies are required.
Refractory ascites arises due to several factors, including spontaneous bacterial peritonitis 15 and VEGF has been reported to be important in the pathogenesis of spontaneous bacterial peritonitis. 16, 17 Results on the VEGF genotype from the present study, showing a correlation between the VEGF C/C genotype and the presence of ascites, support the findings of previous reports. 18 There is now a focus on anti-angiogenic therapy for the treatment of several diseases that involve new blood vessel growth, particularly the treatment of tumours, and several anti-angiogenic agents, such as a VEGF antibody, an inhibitor of the VEGF receptor, a binding antagonist of VEGF and thalidomide have been examined. 19 -21 It is possible that these agents might also be useful for the treatment of refractory ascites.
In conclusion, the present study demonstrated that patients with the VEGF C/C genotype are more likely to develop ascites compared with patients with the T/T or C/T genotypes, suggesting that VEGF genotyping might be a valuable susceptibility marker for ascites formation in cirrhotic patients.
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